sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Let op!
Mogelijk ziet u niet alle beschikbare info op deze pagina, omdat u niet bent ingelogd, of omdat u niet de juiste privileges heeft.

Clinical picture: CLL (Chronical Lymfatic Leukemia)

Trial: HOVON 158 CLL


News
1. Overview
Study details
2. Patient eligibility criteria
3. Registration (& randomization) of patients
4. Participating parties
5. Participating sites
6. Instruction videos
7. Download documentation / forms


return to top

News


No news


1. Overview



Summary

VeNEtoclaX and ibruTinib induction followed by obinutuzumab intenSificaTion Exclusively in CLL Patients not in complete remission or with detectable bone marrow minimal residual disease (NEXT STEP trial)


Status

planned


Members

HOVON, Nordic CLL Group


Study details



Type of study

Prospective Phase II study


Echelon level

Level D


Type of monitoring for this study

Site evaluation visits


Target number of patients

85


2. Patient eligibility criteria



3. Registration (& randomization) of patients



4. Participating parties



5. Participating sites



6. Instruction videos



7. Download documentation / forms




return to top